Form SCHEDULE 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001072613-25-000107
Filing Date
2025-02-10
Accepted
2025-02-10 21:30:19
Documents
3

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13D  
1 primary_doc.xml SCHEDULE 13D 29653
2 AGREEMENT OF JOINT FILING exh1_18925.htm EX-1 14555
3 AGREEMENT OF JOINT FILING exh2_18925.htm EX-2 13510
  Complete submission text file 0001072613-25-000107.txt   59436
Mailing Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631
Business Address 8755 W. HIGGINS ROAD, SUITE 1025 CHICAGO IL 60631 773-380-6600
ARCH Venture Fund XII, L.P. (Filed by) CIK: 0001906837 (see all company filings)

EIN.: 873448430 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D

Mailing Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007
Business Address 3 WORLD TRADE CENTER 175 GREENWICH STREET NEW YORK NY 10007 (212) 784-6595
Metsera, Inc. (Subject) CIK: 0002040807 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13D | Act: 34 | File No.: 005-94832 | Film No.: 25607455
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)